Tandem Diabetes Care, Inc. Basic Shares Outstanding (Weighted Average)
Tandem Diabetes Care, Inc. (TNDM) reported Basic Shares Outstanding (Weighted Average) of 69.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 69.01M shares, a 2.92% increase year-over-year.
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 68.40M shares, a 3.00% increase year-over-year.
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 68.01M shares, a 3.15% increase year-over-year.
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 67.65M shares, a 3.23% increase year-over-year.
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 67.28M shares, a 2.80% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 65.45M shares, a 0.74% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 64.97M shares, a 1.28% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 64.15M shares, a 1.82% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 69.01M shares 10-Q · filed 2026-08-06 | 68.71M shares 10-Q · filed 2026-08-06 | 68.47M shares derived: average of 3 quarters · filed 2026-08-06 | 68.27M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 68.40M shares 10-Q · filed 2026-05-07 | 68.21M shares derived: average of 2 quarters · filed 2026-05-07 | 68.02M shares derived: average of 3 quarters · filed 2026-05-07 | 67.78M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 68.01M shares 10-K · filed 2026-02-19 | 67.83M shares derived: average of 2 quarters · filed 2026-02-19 | 67.57M shares derived: average of 3 quarters · filed 2026-08-06 | 67.28M shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 67.65M shares 10-Q · filed 2025-11-06 | 67.35M shares derived: average of 2 quarters · filed 2026-08-06 | 67.04M shares 10-Q · filed 2025-11-06 | 66.76M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 67.05M shares 10-Q · filed 2026-08-06 | 66.73M shares 10-Q · filed 2026-08-06 | 66.46M shares derived: average of 3 quarters · filed 2026-08-06 | 66.23M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 66.40M shares 10-Q · filed 2026-05-07 | 66.17M shares derived: average of 2 quarters · filed 2026-05-07 | 65.96M shares derived: average of 3 quarters · filed 2026-05-07 | 65.72M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 65.94M shares 10-K · filed 2026-02-19 | 65.74M shares derived: average of 2 quarters · filed 2026-02-19 | 65.49M shares derived: average of 3 quarters · filed 2026-02-19 | 65.45M shares 10-K · filed 2026-02-19 |
| 2024-09-30 | 65.54M shares 10-Q · filed 2025-11-06 | 65.27M shares derived: average of 2 quarters · filed 2025-11-06 | 65.29M shares 10-Q · filed 2025-11-06 | 65.31M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 64.99M shares 10-Q · filed 2025-08-06 | 65.16M shares 10-Q · filed 2025-08-06 | 65.23M shares derived: average of 3 quarters · filed 2025-08-06 | 65.20M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 65.33M shares 10-Q · filed 2025-04-30 | 65.35M shares derived: average of 2 quarters · filed 2025-04-30 | 65.27M shares derived: average of 3 quarters · filed 2025-04-30 | 65.16M shares derived: average of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | 65.37M shares 10-K · filed 2025-02-26 | 65.24M shares derived: average of 2 quarters · filed 2025-02-26 | 65.11M shares derived: average of 3 quarters · filed 2025-02-26 | 64.97M shares 10-K · filed 2026-02-19 |
| 2023-09-30 | 65.12M shares 10-Q · filed 2024-11-06 | 64.97M shares derived: average of 2 quarters · filed 2024-11-06 | 64.83M shares 10-Q · filed 2024-11-06 | 64.72M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 64.83M shares 10-Q · filed 2024-08-01 | 64.69M shares 10-Q · filed 2024-08-01 | 64.59M shares derived: average of 3 quarters · filed 2024-08-01 | 64.50M shares derived: average of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | 64.55M shares 10-Q · filed 2024-05-02 | 64.47M shares derived: average of 2 quarters · filed 2024-05-02 | 64.39M shares derived: average of 3 quarters · filed 2024-05-02 | 64.31M shares derived: average of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | 64.38M shares 10-K · filed 2024-02-21 | 64.31M shares derived: average of 2 quarters · filed 2024-02-21 | 64.23M shares derived: average of 3 quarters · filed 2024-02-21 | 64.15M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 64.24M shares 10-Q · filed 2023-11-01 | 64.16M shares derived: average of 2 quarters · filed 2023-11-01 | 64.07M shares 10-Q · filed 2023-11-01 | 63.96M shares derived: average of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | 64.08M shares 10-Q · filed 2023-08-03 | 63.98M shares 10-Q · filed 2023-08-03 | 63.87M shares derived: average of 3 quarters · filed 2023-08-03 | 63.69M shares derived: average of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 63.88M shares 10-Q · filed 2023-05-03 | 63.77M shares derived: average of 2 quarters · filed 2023-05-03 | 63.57M shares derived: average of 3 quarters · filed 2023-05-03 | 63.35M shares derived: average of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | 63.65M shares 10-K · filed 2023-02-22 | 63.41M shares derived: average of 2 quarters · filed 2023-02-22 | 63.18M shares derived: average of 3 quarters · filed 2023-02-22 | 63.00M shares 10-K · filed 2024-02-21 |
| 2021-09-30 | 63.17M shares 10-Q · filed 2022-11-02 | 62.94M shares derived: average of 2 quarters · filed 2022-11-02 | 62.78M shares 10-Q · filed 2022-11-02 | 62.65M shares derived: average of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | 62.72M shares 10-Q · filed 2022-08-03 | 62.58M shares 10-Q · filed 2022-08-03 | 62.47M shares derived: average of 3 quarters · filed 2022-08-03 | 62.24M shares derived: average of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | 62.45M shares 10-Q · filed 2022-05-04 | 62.35M shares derived: average of 2 quarters · filed 2022-05-04 | 62.08M shares derived: average of 3 quarters · filed 2022-05-04 | 61.66M shares derived: average of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | 62.25M shares 10-K · filed 2022-02-22 | 61.89M shares derived: average of 2 quarters · filed 2022-02-22 | 61.40M shares derived: average of 3 quarters · filed 2022-02-22 | 60.99M shares 10-K · filed 2023-02-22 |
| 2020-09-30 | 61.53M shares 10-Q · filed 2021-11-03 | 60.98M shares derived: average of 2 quarters · filed 2021-11-03 | 60.57M shares 10-Q · filed 2021-11-03 | |
| 2020-06-30 | 60.42M shares 10-Q · filed 2021-08-04 | 60.08M shares 10-Q · filed 2021-08-04 | ||
| 2019-12-31 | 59.22M shares 10-K · filed 2021-02-24 | 59.01M shares derived: average of 2 quarters · filed 2021-02-24 | 58.51M shares 10-K · filed 2022-02-22 | |
| 2019-09-30 | 58.80M shares 10-K · filed 2021-02-24 | 58.27M shares 10-Q · filed 2020-11-05 | ||
| 2018-09-30 | 55.62M shares 10-Q · filed 2019-11-04 | 44.99M shares 10-Q · filed 2019-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |